Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into
(AARTIDRUGS)
XNSE:AARTIDRUGS, XBOM:AARTIDRUGS
Aarti Drugs Ltd Q4FY24; 16% fall in Profits
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into
Aarti Drugs Ltd Q2FY24; 5% fall in Profits
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into
Aarti Drugs Ltd Q1FY24; 54% rise in Profits.
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into
Aarti Drugs Limited (AARTIDRUGS) Q4 FY23 Earnings Concall Transcript
Aarti Drugs Limited (NSE:AARTIDRUGS) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Adhish Patil -- Chief Financial Officer Harshit M. Savla -- Joint Managing
Earnings | Aarti Drugs Ltd. (NSE: AARTIDRUGS): Q4FY23 Results Out; Total Income rise 8.5% YoY
Aarti Drugs Ltd. is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs), intermediates,
Earnings|Aarti Drugs Ltd (NSE:AARTIDRUGS): Q3FY23 Results Out; Total Income rise 4% YoY
Aarti Drugs Ltd (NSE:AARTIDRUGS) is a leading Indian pharmaceutical company that specializes in the manufacture and export of bulk drugs. The company
Aarti Drugs Ltd. (AARTIDRUGS) Q2 FY23 Earnings Concall Transcript
Aarti Drugs Ltd. (NSE:AARTIDRUGS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Adhish P. Patil -- Chief Financial Officer Vishwa Savla -- Managing Director
Aarti Drugs Ltd. (AARTIDRUGS) Q4 FY22 Earnings Concall Transcript
Aarti Drugs Ltd. (NSE: AARTIDRUGS) Q4 FY22 Earnings Concall dated May. 10, 2022 Corporate Participants: Adhish Patil -- Chief Financial Officer Ankush Mahajan -- Axis Securities